The ophthalmology sector continues to be a robust market entering Q2 2023. There are more than 25 core private equity platforms within ophthalmology, plus smaller regional PE-backed groups. Read more here.
The ophthalmology sector continues to be a robust market entering Q2 2023. There are more than 25 core private equity platforms within ophthalmology, plus smaller regional PE-backed groups. Read more here.